DETAILS, FICTION AND ABBV-744 IN ACUTE MYELOID LEUKEMIA (AML)

The current work examined the potential of using ARV-825 and ABBV-744 to improve the effectiveness of tamoxifen or fulvestrant furthermore palbociclib. ARV-825 was effective in both equally p53 wild-kind (WT) breast tumor cells and in cells lacking purposeful p53 possibly alone or in combination with tamoxifen, although the effectiveness of ABBV-74